570 related articles for article (PubMed ID: 17616479)
21. Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma.
Lu H; Zhou L; Zuo H; Le W; Hu J; Zhang T; Li M; Yuan Y
Cancer Chemother Pharmacol; 2021 Feb; 87(2):217-228. PubMed ID: 33226447
[TBL] [Abstract][Full Text] [Related]
22. Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.
Adachi R; Ogawa K; Matsumoto SI; Satou T; Tanaka Y; Sakamoto J; Nakahata T; Okamoto R; Kamaura M; Kawamoto T
Eur J Med Chem; 2017 Aug; 136():283-293. PubMed ID: 28505533
[TBL] [Abstract][Full Text] [Related]
23. Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1.
Deevska GM; Dotson PP; Karakashian AA; Isaac G; Wrona M; Kelly SB; Merrill AH; Nikolova-Karakashian MN
J Biol Chem; 2017 Mar; 292(12):5110-5122. PubMed ID: 28087695
[TBL] [Abstract][Full Text] [Related]
24. Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene.
Burns TA; Subathra M; Signorelli P; Choi Y; Yang X; Wang Y; Villani M; Bhalla K; Zhou D; Luberto C
J Lipid Res; 2013 Mar; 54(3):794-805. PubMed ID: 23160178
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
[TBL] [Abstract][Full Text] [Related]
26. Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail, which is involved in its localization in plasma membranes.
Tani M; Kuge O
Biochem Biophys Res Commun; 2009 Apr; 381(3):328-32. PubMed ID: 19233134
[TBL] [Abstract][Full Text] [Related]
27. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
28. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
[TBL] [Abstract][Full Text] [Related]
29. Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts.
Van der Luit AH; Budde M; Zerp S; Caan W; Klarenbeek JB; Verheij M; Van Blitterswijk WJ
Biochem J; 2007 Jan; 401(2):541-9. PubMed ID: 17049047
[TBL] [Abstract][Full Text] [Related]
30. Sphingomyelin in microdomains of the plasma membrane regulates amino acid-stimulated mTOR signal activation.
Zama K; Mitsutake S; Okazaki T; Igarashi Y
Cell Biol Int; 2018 Jul; 42(7):823-831. PubMed ID: 29369436
[TBL] [Abstract][Full Text] [Related]
31. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation.
Hailemariam TK; Huan C; Liu J; Li Z; Roman C; Kalbfeisch M; Bui HH; Peake DA; Kuo MS; Cao G; Wadgaonkar R; Jiang XC
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1519-26. PubMed ID: 18566297
[TBL] [Abstract][Full Text] [Related]
32. Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels.
Hayashi Y; Nemoto-Sasaki Y; Matsumoto N; Hama K; Tanikawa T; Oka S; Saeki T; Kumasaka T; Koizumi T; Arai S; Wada I; Yokoyama K; Sugiura T; Yamashita A
J Biol Chem; 2018 Nov; 293(45):17505-17522. PubMed ID: 30242129
[TBL] [Abstract][Full Text] [Related]
33. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
Miyaji M; Jin ZX; Yamaoka S; Amakawa R; Fukuhara S; Sato SB; Kobayashi T; Domae N; Mimori T; Bloom ET; Okazaki T; Umehara H
J Exp Med; 2005 Jul; 202(2):249-59. PubMed ID: 16009715
[TBL] [Abstract][Full Text] [Related]
34. Regulation of membrane KCNQ1/KCNE1 channel density by sphingomyelin synthase 1.
Wu M; Takemoto M; Taniguchi M; Takumi T; Okazaki T; Song WJ
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C15-23. PubMed ID: 27194473
[TBL] [Abstract][Full Text] [Related]
35. Effect of Total SMS Activity on LDL Catabolism in Mice.
Li Z; He M; Chen G; Souaiaia T; Worgall TS; Jiang XC
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1251-1261. PubMed ID: 37128925
[TBL] [Abstract][Full Text] [Related]
36. Carboxyl-terminal Tail-mediated Homodimerizations of Sphingomyelin Synthases Are Responsible for Efficient Export from the Endoplasmic Reticulum.
Hayashi Y; Nemoto-Sasaki Y; Matsumoto N; Tanikawa T; Oka S; Tanaka Y; Arai S; Wada I; Sugiura T; Yamashita A
J Biol Chem; 2017 Jan; 292(3):1122-1141. PubMed ID: 27927984
[TBL] [Abstract][Full Text] [Related]
37. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
[TBL] [Abstract][Full Text] [Related]
38. SMS regulates the expression and function of P-gp and MRP2 in Caco-2 cells.
Jin G; Li Y; Zhu Y; Du L; Yan J; Yang Q
Cell Biol Toxicol; 2016 Dec; 32(6):483-497. PubMed ID: 27394416
[TBL] [Abstract][Full Text] [Related]
39. Sphingomyelin Synthase Family and Phospholipase Cs.
Jiang XC; Chiang YP
Adv Exp Med Biol; 2022; 1372():77-86. PubMed ID: 35503176
[TBL] [Abstract][Full Text] [Related]
40. Methods to Characterize Synthesis and Degradation of Sphingomyelin at the Plasma Membrane and Its Impact on Lipid Raft Dynamics.
Nikolova-Karakashian M
Methods Mol Biol; 2021; 2187():113-129. PubMed ID: 32770504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
